跳至主要内容
临床试验/NL-OMON41962
NL-OMON41962已完成不适用

PROSPECTIVE STUDY OF THE PROGNOSTIC VALUE OF TRANSIENT ELASTOMETRY (FIBROSCAN) IN PRIMARY SCLEROSING CHOLANGITIS (PSC) PATIENTS (FICUS STUDY) - FICUS study

MD0 个研究点目标入组 50 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
MD
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • 1. PSC diagnosis as defined by the European Association for the Study of the Liver (EASL)
  • Practice Guidelines, including subgroups such as small duct PSC and auto-immune hepatitis *PSC overlap syndromes. There are no prohibited medications.
  • 2. Age > 18 years and < 75 years
  • 3. Written informed consent

排除标准

  • 1. Secondary sclerosing cholangitis (including IgG4-associated cholangitis)
  • 2. Previous liver transplantation
  • 3. Listed for liver transplantation
  • 4. Presence of complication (ascites, encephalopathy, hepato-biliary malignancy)
  • 5. Coexistent conditions that would limit life expectancy to less than 1 year
  • 6. Associated liver disease of other etiology (chronic hepatitis B or C, chronic alcoholic liver disease, nonalcoholic steatohepatitis (NASH), hemochromatosis, Wilson*s disease or other significant liver disease)
  • 7. Known pregnancy

研究者

发起方
MD

相似试验